US Stock MarketDetailed Quotes
VERV Verve Therapeutics
- 4.600
- +0.050+1.10%
Close Nov 21 16:00 ET
- 4.640
- +0.040+0.87%
Post 19:19 ET
389.45MMarket Cap-1869P/E (TTM)
4.690High4.440Low1.40MVolume4.550Open4.550Pre Close6.41MTurnover2.23%Turnover RatioLossP/E (Static)84.66MShares19.34052wk High0.77P/B289.08MFloat Cap4.30552wk Low--Dividend TTM62.84MShs Float78.000Historical High--Div YieldTTM5.50%Amplitude4.305Historical Low4.587Avg Price1Lot Size
About Verve Therapeutics Company
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Company Profile
SymbolVERV
Company NameVerve Therapeutics
Listing DateJun 17, 2021
Issue Price19.00
Founded2018
CEODr. Sekar Kathiresan, M.D.
MarketNASDAQ
Employees255
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-617-603-0070
Websitehttp://www.vervetx.com
Company Executives
- Name
- Position
- Salary
- Dr. Sekar Kathiresan, M.D.
- Chief Executive Officer and Director
- 9.32M
- Dr. Ourania Tatsis, PhD
- Director; Executive Vice President and Chief Regulatory and Quality Officer of Vertex Pharmaceuticals
- --
- Joan Nickerson
- Chief Administrative Officer
- --
- Allison Dorval
- Chief Financial Officer and Principal Accounting Officer
- 3.48M
- Troy Lister, PhD
- Chief Scientific Officer
- --
- Andrew D. Ashe, J.D.
- President and Chief Operating Officer
- --
- Frederick Fiedorek, M.D.
- Chief Medical Officer
- --
- Dr. Burt A. Adelman, M.D.
- Chairman of the Board
- 451.88K
- Jodie P. Morrison
- Independent Director
- --
- Alexander G. Cumbo
- Independent Director
- 405.88K
- Dr. Krishna Yeshwant, M.D.
- Independent Director
- 410.88K
- Sheila Mikhail, J.D.
- Independent Director
- 412.38K
- Michael F. Maclean
- Independent Director
- 521.07K
- Lonnel Coats
- Independent Director
- 407.38K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data